- Investing Ideas
- /
- U.S. High Growth Tech and AI Stocks
U.S. High Growth Tech and AI Stocks
Results
222
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
222 companies
Commvault Systems
Market Cap: US$7.4b
Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.
CVLT
US$165.97
7D
-2.9%
1Y
35.8%
Quoin Pharmaceuticals
Market Cap: US$4.9m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$8.56
7D
-2.1%
1Y
-60.6%
Unicycive Therapeutics
Market Cap: US$58.3m
A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.
UNCY
US$4.85
7D
4.3%
1Y
10.2%
Vertex Pharmaceuticals
Market Cap: US$122.5b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$472.27
7D
1.9%
1Y
-4.1%
CleanSpark
Market Cap: US$3.5b
Operates as a bitcoin mining company in the Americas.
CLSK
US$12.34
7D
-4.9%
1Y
-23.7%
BeOne Medicines
Market Cap: US$35.0b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$296.46
7D
2.1%
1Y
81.6%
Anavex Life Sciences
Market Cap: US$1.1b
Operates as a biopharmaceutical company.
AVXL
US$12.74
7D
15.2%
1Y
86.3%
Krystal Biotech
Market Cap: US$4.4b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$150.00
7D
-0.1%
1Y
-28.8%
Semrush Holdings
Market Cap: US$1.5b
Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.
SEMR
US$9.58
7D
5.7%
1Y
-32.3%
Glimpse Group
Market Cap: US$33.5m
An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.
VRAR
US$1.60
7D
8.8%
1Y
73.8%
Fennec Pharmaceuticals
Market Cap: US$241.1m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$8.72
7D
-0.3%
1Y
31.9%
Amicus Therapeutics
Market Cap: US$1.9b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$6.28
7D
-0.2%
1Y
-38.8%
Evaxion
Market Cap: US$16.9m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.71
7D
2.3%
1Y
-81.4%
MNTN
Market Cap: US$2.2b
A performance TV software company, provides performance advertising services in the United States.
MNTN
US$29.18
7D
4.8%
1Y
n/a
Protalix BioTherapeutics
Market Cap: US$127.4m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.55
7D
3.3%
1Y
34.8%
BitFuFu
Market Cap: US$665.5m
Provides digital asset mining solutions in North America, Asia, Europe, and internationally.
FUFU
US$4.01
7D
3.4%
1Y
-20.0%
Day One Biopharmaceuticals
Market Cap: US$703.5m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$7.21
7D
10.9%
1Y
-54.6%
Creative Medical Technology Holdings
Market Cap: US$7.1m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$2.72
7D
3.8%
1Y
-23.5%
Clene
Market Cap: US$33.6m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$3.66
7D
-6.2%
1Y
-17.9%
Trade Desk
Market Cap: US$41.6b
Operates as a technology company in the United States and internationally.
TTD
US$85.00
7D
4.4%
1Y
-6.5%
ImmunityBio
Market Cap: US$2.6b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$3.01
7D
6.4%
1Y
-45.2%
Take-Two Interactive Software
Market Cap: US$41.8b
Develops, publishes, and markets interactive entertainment solutions for consumers worldwide.
TTWO
US$225.75
7D
-3.5%
1Y
50.2%
ServiceNow
Market Cap: US$198.4b
Provides cloud-based solution for digital workflows in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally.
NOW
US$996.18
7D
3.9%
1Y
20.2%
Bit Digital
Market Cap: US$1.1b
Engages in the bitcoin mining business.
BTBT
US$3.23
7D
-19.5%
1Y
-8.5%
IREN
Market Cap: US$4.6b
Operates in the integrated data center business.
IREN
US$18.14
7D
0.5%
1Y
92.4%
Corning
Market Cap: US$47.8b
Operates in optical communications, display technologies, environmental technologies, specialty materials, and life sciences businesses.
GLW
US$55.72
7D
2.8%
1Y
30.2%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Protagonist Therapeutics
Market Cap: US$3.4b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$53.74
7D
-4.8%
1Y
29.3%
Bitdeer Technologies Group
Market Cap: US$2.9b
Operates as a technology company for blockchain and high-performance computing (HPC) in Singapore, the United States, Bhutan, and Norway.
BTDR
US$15.16
7D
10.3%
1Y
57.1%
Apellis Pharmaceuticals
Market Cap: US$2.5b
A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
APLS
US$20.09
7D
0.2%
1Y
-48.3%
Zai Lab
Market Cap: US$4.1b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$37.77
7D
4.9%
1Y
100.2%
AmpliTech Group
Market Cap: US$55.3m
Designs, engineers, and assembles micro-wave component-based amplifiers.
AMPG
US$3.16
7D
7.8%
1Y
168.9%
Geron
Market Cap: US$847.1m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.28
7D
-0.8%
1Y
-70.2%
Aprea Therapeutics
Market Cap: US$10.7m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.93
7D
15.6%
1Y
-50.0%
Applied Optoelectronics
Market Cap: US$1.5b
Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.
AAOI
US$25.84
7D
-12.2%
1Y
200.1%
Arcturus Therapeutics Holdings
Market Cap: US$419.0m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$14.95
7D
10.4%
1Y
-34.9%